Biovaxys Technology Corp Stock Buy Hold or Sell Recommendation
| BVAXF Stock | USD 0.06 0 3.51% |
Assuming the 90 days horizon and your highly speculative risk level, our recommendation regarding Biovaxys Technology Corp is 'Strong Sell'. Macroaxis provides Biovaxys Technology buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BVAXF positions. The advice algorithm takes into account all of Biovaxys Technology's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Biovaxys Technology's buy or sell advice are summarized below:
Real Value 0.0468 | Hype Value 0.06 | Market Value 0.0566 | Naive Value 0.0459 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Biovaxys Technology Corp given historical horizon and risk tolerance towards Biovaxys Technology. When Macroaxis issues a 'buy' or 'sell' recommendation for Biovaxys Technology Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Biovaxys |
Execute Biovaxys Technology Buy or Sell Advice
The Biovaxys recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Biovaxys Technology Corp. Macroaxis does not own or have any residual interests in Biovaxys Technology Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Biovaxys Technology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Biovaxys Technology Trading Alerts and Improvement Suggestions
| Biovaxys Technology is way too risky over 90 days horizon | |
| Biovaxys Technology has some characteristics of a very speculative penny stock | |
| Biovaxys Technology appears to be risky and price may revert if volatility continues | |
| Biovaxys Technology has high likelihood to experience some financial distress in the next 2 years | |
| The company has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Biovaxys Technology until it has trouble settling it off, either with new capital or with free cash flow. So, Biovaxys Technology's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biovaxys Technology Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biovaxys to invest in growth at high rates of return. When we think about Biovaxys Technology's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.46 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biovaxys Technology Corp has accumulated about 39.05 K in cash with (5.29 M) of positive cash flow from operations. | |
| Roughly 19.0% of the company shares are held by company insiders |
Biovaxys Technology Returns Distribution Density
The distribution of Biovaxys Technology's historical returns is an attempt to chart the uncertainty of Biovaxys Technology's future price movements. The chart of the probability distribution of Biovaxys Technology daily returns describes the distribution of returns around its average expected value. We use Biovaxys Technology Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Biovaxys Technology returns is essential to provide solid investment advice for Biovaxys Technology.
| Mean Return | 1.08 | Value At Risk | -11.69 | Potential Upside | 24.55 | Standard Deviation | 10.11 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Biovaxys Technology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Biovaxys Technology Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Biovaxys Technology or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Biovaxys Technology's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Biovaxys otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 1.13 | |
β | Beta against NYSE Composite | -1.44 | |
σ | Overall volatility | 9.80 | |
Ir | Information ratio | 0.10 |
Biovaxys Technology Volatility Alert
Biovaxys Technology Corp is displaying above-average volatility over the selected time horizon. Biovaxys Technology Corp is a penny stock. Although Biovaxys Technology may be in fact a good investment, many penny otc stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Biovaxys Technology Corp. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Biovaxys instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Biovaxys Technology Fundamentals Vs Peers
Comparing Biovaxys Technology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biovaxys Technology's direct or indirect competition across all of the common fundamentals between Biovaxys Technology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biovaxys Technology or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Biovaxys Technology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Biovaxys Technology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Biovaxys Technology to competition |
| Fundamentals | Biovaxys Technology | Peer Average |
| Return On Equity | -0.73 | -0.31 |
| Return On Asset | -0.38 | -0.14 |
| Current Valuation | 11.35 M | 16.62 B |
| Shares Outstanding | 106.72 M | 571.82 M |
| Shares Owned By Insiders | 18.94 % | 10.09 % |
| Price To Earning | (4.32) X | 28.72 X |
| Price To Book | 2.53 X | 9.51 X |
| EBITDA | (6.44 M) | 3.9 B |
| Net Income | (6.46 M) | 570.98 M |
| Cash And Equivalents | 39.05 K | 2.7 B |
| Current Ratio | 0.16 X | 2.16 X |
| Book Value Per Share | 0.06 X | 1.93 K |
| Cash Flow From Operations | (5.29 M) | 971.22 M |
| Earnings Per Share | (0.05) X | 3.12 X |
| Number Of Employees | 17 | 18.84 K |
| Beta | -0.59 | -0.15 |
| Market Capitalization | 8.73 M | 19.03 B |
| Total Asset | 8.5 M | 29.47 B |
| Retained Earnings | (80 M) | 9.33 B |
| Working Capital | 35 M | 1.48 B |
| Current Asset | 37 M | 9.34 B |
| Current Liabilities | 2 M | 7.9 B |
| Z Score | -7.8 | 8.72 |
| Net Asset | 8.5 M |
Biovaxys Technology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Biovaxys . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0972 | |||
| Daily Balance Of Power | 0.3491 | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 0.0539 | |||
| Day Typical Price | 0.0548 | |||
| Market Facilitation Index | 0.0055 | |||
| Price Action Indicator | 0.0037 | |||
| Period Momentum Indicator | 0.0019 | |||
| Relative Strength Index | 57.18 |
About Biovaxys Technology Buy or Sell Advice
When is the right time to buy or sell Biovaxys Technology Corp? Buying financial instruments such as Biovaxys OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Biovaxys Technology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Biotech Thematic Idea Now
Biotech
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Biovaxys Technology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Biovaxys OTC Stock analysis
When running Biovaxys Technology's price analysis, check to measure Biovaxys Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovaxys Technology is operating at the current time. Most of Biovaxys Technology's value examination focuses on studying past and present price action to predict the probability of Biovaxys Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovaxys Technology's price. Additionally, you may evaluate how the addition of Biovaxys Technology to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |